Functional responses of isolated human seminal vesicle tissue to selective phosphodiesterase inhibitors

被引:27
作者
Ueckert, Stefan [1 ]
Bazrafshan, Siamak
Scheller, Friedemann
Mayer, Margit E.
Jonas, Udo
Stief, Christian G.
机构
[1] Hannover Med Sch, Dept Urol, D-30623 Hannover, Germany
[2] Hannover Med Sch, Dept Nucl Med, D-30623 Hannover, Germany
[3] IPF Pharmaceut GmbH, Urol Res Unit, Hannover, Germany
[4] Univ Munich, Dept Urol, Fac Med, Munich, Germany
[5] Acad Hosp Grosshadern, Munich, Germany
关键词
D O I
10.1016/j.urology.2007.02.049
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES To further elucidate the significance of the cyclic nucleotide-mediated signal transduction, we examined the in vitro functional responses of isolated seminal vesicle (SV) smooth muscle tissue to selective phosphodiesterase (PDE) inhibitors. METHODS Using the organ bath technique, the effects of increasing concentrations (1 nM to 10 AM) of the PDE inhibitors vinpocetine (PDE1 inhibitor), rolipram PDE4 inhibitor), and sildenafil and vardenafil (PDE5 inhibitors) on the tension induced by 10 AM of norepinephrine on SV tissue strips were investigated. To examine the drug effects on the tissue levels of cyclic guanosine monophosphate (cGMP) and cyclic adenosine monophosphate (cAMP), the SV strips were exposed to different concentrations of the compounds (0.1, 1, and 10 AM). After freezing, homogenization, and extraction of cyclic nucleotides, cAMP and cGMP were measured using radioimmunoassays. In the experiments, sodium nitroprusside and forskolin were used as reference compounds. RESULTS The norepinephrine-induced tension was reversed by the drugs in a dose-dependent manner. The rank order of efficacy was rolipram greater than sildenafil greater than vardenafil greater than or equal to vinpocetine greater than sodium nitroprusside greater than forskolin. The reversion of the norepinephrine-induced tension at maximum drug concentration ranged from 79% (rolipram) to 32% (forskolin). Only rolipram and sildenafil reached a median effective concentration. The effects of the PDE inhibitors were paralleled by a 1.7-fold to 173-fold increase in tissue cGMP or cAMP. CONCLUSIONS Our results have demonstrated that PDE inhibitors can reverse the adrenergic tension of human SV tissue and increase levels of cyclic nucleotides. This outlines the potential significance of cAMP and cGMP in the control of SV smooth muscle function. These findings might be of importance with regard to the pharmacologic treatment of premature ejaculation.
引用
收藏
页码:185 / 189
页数:5
相关论文
共 21 条
[1]   Phosphodiesterase 5 inhibitors in rapid ejaculation - Potential use and possible mechanisms of action [J].
Abdel-Hamid, IA .
DRUGS, 2004, 64 (01) :13-26
[2]  
ANDERSON KE, 1993, PHARMACOL REV, V45, P253
[3]   Pharmacology of the lower urinary tract: Basis for current and future treatments of urinary incontinence [J].
Andersson, KE ;
Wein, AJ .
PHARMACOLOGICAL REVIEWS, 2004, 56 (04) :581-631
[4]   The effect of the specific phosphodiesterase-IV-inhibitor rolipram on the ureteral peristalsis of the rabbit in vitro and in vivo [J].
Becker, AJ ;
Stief, CG ;
Meyer, M ;
Truss, MC ;
Forssmann, WG ;
Jonas, U .
JOURNAL OF UROLOGY, 1998, 160 (03) :920-925
[5]   Safety and efficacy of sildenafil citrate for the treatment of female sexual arousal disorder: A double-blind, placebo controlled study [J].
Berman, JR ;
Berman, LA ;
Toler, SM ;
Gill, J ;
Haughie, S .
JOURNAL OF UROLOGY, 2003, 170 (06) :2333-2338
[6]   Is glandular formation of nitric oxide a prerequisite for muscarinic secretion of fructose in the guinea-pig seminal vesicle? [J].
Ehren, I ;
Sjostrand, NO ;
Hammarstrom, M ;
Wiklund, NP .
UROLOGICAL RESEARCH, 1997, 25 (06) :433-438
[7]   EFFECTS OF VINPOCETINE ON CYCLIC-NUCLEOTIDE METABOLISM IN VASCULAR SMOOTH-MUSCLE [J].
HAGIWARA, M ;
ENDO, T ;
HIDAKA, H .
BIOCHEMICAL PHARMACOLOGY, 1984, 33 (03) :453-457
[8]   Effects of various nitric oxide donating agents on the contractility and cyclic nucleotide turnover of human seminal vesicles in vitro [J].
Heuer, O ;
Ückert, S ;
Machtens, SA ;
Stief, CG ;
Tsikas, D ;
Frölich, JC ;
Jonas, U .
UROLOGY, 2002, 59 (06) :958-962
[9]   Phosphodiesterase: overview of protein structures, potential therapeutic applications and recent progress in drug development [J].
Jeon, YH ;
Heo, YS ;
Kim, CM ;
Hyun, YL ;
Lee, TG ;
Ro, S ;
Cho, JM .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2005, 62 (11) :1198-1220
[10]  
KATSUKI S, 1977, J CYCLIC NUCL PROT, V3, P23